Indra, Radek
53  results:
Search for persons X
?
5

Identification of human enzymes oxidizing the anti-thyroid-..:

Indra, Radek ; Pompach, Petr ; Martínek, Václav...
Indra , R , Pompach , P , Martínek , V , Takácsová , P , Vavrová , K , Heger , Z , Adam , V , Eckschlager , T , Kopečková , K , Arlt , V M & Stiborová , M 2019 , ' Identification of human enzymes oxidizing the anti-thyroid-cancer drug Vandetanib and explanation of the high efficiency of cytochrome P450 3A4 in its oxidation ' , International Journal of Molecular Sciences , vol. 20 , no. 14 , 3392 . https://doi.org/10.3390/ijms20143392.  , 2019
 
?
6

Application of hepatic cytochrome b 5 /P450 reductase null ..:

Reed, Lindsay ; Indra, Radek ; Mrizova, Iveta...
Reed , L , Indra , R , Mrizova , I , Moserova , M , Schmeiser , H H , Wolf , C R , Henderson , C J , Stiborova , M , Phillips , D H & Arlt , V M 2019 , ' Application of hepatic cytochrome b 5 /P450 reductase null (HBRN) mice to study the role of cytochrome b 5 in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine ' , Toxicology and Applied Pharmacology , vol. 366 , pp. 64-74 . https://doi.org/10.1016/j.taap.2019.01.020.  , 2019
 
?
7

Identification of human enzymes oxidizing the anti-thyroid-..:

Indra, Radek ; Pompach, Petr ; Martínek, Václav...
Indra , R , Pompach , P , Martínek , V , Takácsová , P , Vavrová , K , Heger , Z , Adam , V , Eckschlager , T , Kopečková , K , Arlt , V M & Stiborová , M 2019 , ' Identification of human enzymes oxidizing the anti-thyroid-cancer drug Vandetanib and explanation of the high efficiency of cytochrome P450 3A4 in its oxidation ' , International Journal of Molecular Sciences , vol. 20 , no. 14 , 3392 . https://doi.org/10.3390/ijms20143392.  , 2019
 
?
10

Tyrosine kinase inhibitors vandetanib, lenvatinib and caboz..:

Kolarik, Matus ; Indra, Radek ; Adam, Vojtech...
Kolarik , M , Indra , R , Adam , V , Heger , Z , Kopeckova , K , Arlt , V M & Stiborova , M 2019 , ' Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro ' , Neuroendocrinology Letters , vol. 39 , no. 7 , pp. 515-524 ..  , 2019
 
?
11

Ellipticine-loaded apoferritin nanocarrier retains DNA addu..:

Indra, Radek ; Černá, Tereza ; Heger, Zbyněk...
Indra , R , Černá , T , Heger , Z , Hraběta , J , Wilhelm , M , Dostálová , S , Lengálová , A , Martínková , M , Adam , V , Eckschlager , T , Schmeiser , H H , Arlt , V M & Stiborová , M 2019 , ' Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells ' , Toxicology , vol. 419 , pp. 40-54 . https://doi.org/10.1016/j.tox.2019.03.009.  , 2019
 
?
12

Ellipticine-loaded apoferritin nanocarrier retains DNA addu..:

Indra, Radek ; Černá, Tereza ; Heger, Zbyněk...
Indra , R , Černá , T , Heger , Z , Hraběta , J , Wilhelm , M , Dostálová , S , Lengálová , A , Martínková , M , Adam , V , Eckschlager , T , Schmeiser , H H , Arlt , V M & Stiborová , M 2019 , ' Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells ' , Toxicology , vol. 419 , pp. 40-54 . https://doi.org/10.1016/j.tox.2019.03.009.  , 2019
 
?
13

The impact of p53 on aristolochic acid I-induced nephrotoxi..:

Sborchia, Mateja ; De Prez, Eric G ; Antoine, Marie Hélène...
Sborchia , M , De Prez , E G , Antoine , M H , Bienfait , L , Indra , R , Valbuena , G , Phillips , D H , Nortier , J L , Stiborová , M , Keun , H C & Arlt , V M 2019 , ' The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro ' , Archives of Toxicology , vol. 93 , no. 11 , pp. 3345-3366 . https://doi.org/10.1007/s00204-019-02578-4.  , 2019
 
?
14

Application of hepatic cytochrome b 5 /P450 reductase null ..:

Reed, Lindsay ; Indra, Radek ; Mrizova, Iveta...
Reed , L , Indra , R , Mrizova , I , Moserova , M , Schmeiser , H H , Wolf , C R , Henderson , C J , Stiborova , M , Phillips , D H & Arlt , V M 2019 , ' Application of hepatic cytochrome b 5 /P450 reductase null (HBRN) mice to study the role of cytochrome b 5 in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine ' , Toxicology and Applied Pharmacology , vol. 366 , pp. 64-74 . https://doi.org/10.1016/j.taap.2019.01.020.  , 2019
 
?
15

The impact of p53 on aristolochic acid I-induced nephrotoxi..:

Sborchia, Mateja ; De Prez, Eric G ; Antoine, Marie Hélène...
Sborchia , M , De Prez , E G , Antoine , M H , Bienfait , L , Indra , R , Valbuena , G , Phillips , D H , Nortier , J L , Stiborová , M , Keun , H C & Arlt , V M 2019 , ' The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro ' , Archives of Toxicology , vol. 93 , no. 11 , pp. 3345-3366 . https://doi.org/10.1007/s00204-019-02578-4.  , 2019
 
1-15